Moving the elements of life
Tailored manufacturing grades
cGMP -
Clinical Quality
Advanced Technologies for Clinical Readiness
BioSpring leverages industry-leading oligonucleotide manufacturing technologies to ensure the highest quality material, precisely engineered for clinical success. BioSpring’s robust development capabilities built on three decades of experience support seamless transitions between clinical phases with no compromise on quality, compliance, or timelines. For a streamlined development and scale-up, platform processes and methods can be leveraged. In addition, we also routinely work with client-defined processes to ensure full flexibility. Whether leveraging BioSpring’s established workflows or implementing your own, we support seamless transitions between clinical phases, with no compromise on quality, compliance, or timelines. synthesis, purification, and analytical technologies, ensuring identity, purity, and activity of clinical-grade oligonucleotides. We support ICH-compliant, stage-appropriate analytical method development and validation, from early-stage development through the clinical phases and beyond.
State-Of-The-Art Facilities for Flexible Scaling
Our GMP-certified, FDA- and ANVISA-inspected facilities support batch sizes from grams to tens of kilograms.
Decades of Clinical Expertise
BioSpring has manufactured APIs for hundreds of clinical trials worldwide, combining technical expertise with a proven track record of reliability and on-time delivery. Our regulatory support team supports your program with the preparation of scientific advice meetings, dossier sections, and review of global submissions including INDs, IMPDs, NDAs, MAAs, J-NDAs, and BLAs.
